Wasatch Advisors’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Wasatch Advisors’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-326,449	Closed	-$4.17M	–	233
2018 Q4	$4.17M	Sell	326,449 -517,470	-61%	-$7.85M	0.06%	171
2018 Q3	$13.7M	Sell	843,919 -39,842	-5%	-$570K	0.16%	101
2018 Q2	$11.4M	Buy	883,761 +138,571	+19%	+$1.87M	0.14%	105
2018 Q1	$9.28M	Buy	745,190 +179,258	+32%	+$2.18M	0.12%	114
2017 Q4	$7.91M	Sell	565,932 -8,242	-1%	-$121K	0.1%	131
2017 Q3	$9.65M	Buy	574,174 +150,343	+35%	+$2.45M	0.13%	116
2017 Q2	$7.13M	Buy	423,831 +108,154	+34%	+$1.62M	0.1%	134
2017 Q1	$4.89M	Sell	315,677 -220	-0.1%	-$3.14K	0.07%	170
2016 Q4	$4.72M	Buy	315,897 +45,000	+17%	+$632K	0.07%	173
2016 Q3	$3.4M	Sell	270,897 -3,301	-1%	-$33.1K	0.05%	221
2016 Q2	$2.47M	Buy	274,198 +86,547	+46%	+$848K	0.04%	242
2016 Q1	$1.74M	Buy	187,651 +201	+0.1%	+$2.06K	0.03%	269
2015 Q4	$2.16M	Buy	187,450 +9,688	+5%	+$120K	0.03%	270
2015 Q3	$2.4M	Buy	177,762 +125,780	+242%	+$1.7M	0.03%	273
2015 Q2	$720K	Buy	+51,982	New	+$703K	0.01%	355

Other funds holding OXFD

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

Wasatch Advisors's OXFD Position: Q1 2019 in Review

Wasatch Advisors sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2019, closing a stake of 326,449 shares — an estimated $4.17M sold.

Wasatch Advisors first reported a position in OXFD in Q2 2015 and held it in 15 quarters. The position peaked at $13.7M in Q3 2018. 92 funds tracked by Wall St. Rank hold OXFD as of Q1 2019.

Wasatch Advisors reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2019 after selling out during the quarter.
Wasatch Advisors sold 326,449 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2019, an estimated $4.17M.
Wasatch Advisors first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q2 2015 and held it in 15 quarters.
Wasatch Advisors's Oxford Immunotec Global PLC Ordinary Shares position peaked at $13.7M in Q3 2018.
92 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2019.

Based on Wasatch Advisors's 13F filing for Q1 2019, filed 8 May 2019.